Zai Lab Ltd (ZLAB): Net Income
-$175.54M
Year ended 2025-12-31
-$188.21M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$175.54M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$257.10M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$334.62M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$443.29M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$704.47M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$268.90M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$195.07M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$139.07M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$50.38M | n/m | 2020-04-29, From 2017-01-01 |
| 2016-12-31 | -$37.51M | n/m | 2019-03-29, From 2016-01-01 |
| 2015-12-31 | -$18.02M | n/a | 2018-04-30, From 2015-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$175.54M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$25.55M | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$732.94M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $271.17M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$61.60M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$23.36M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$198.84M | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $456.91M | n/m |
Compare ZLAB, NATR, TVTX, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗